Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec
As Pfizer endeavors to stymie a suite of bacterial infections, the COVID-19 vaccine maker continues to keep an eye on emerging public health threats.
Darren Incorvaia
May 20, 2026 5:05am
CellCentric raises $220M to advance myeloma drug
May 6, 2026 7:00am
Pfizer’s $2.3B bet ends in failure as CD47 blocker scrapped
May 5, 2026 9:15am
Helus CEO out after two months—Chutes & Ladders
Apr 24, 2026 8:30am
Pfizer cans work on next-gen conjugate in cancer patients
Apr 23, 2026 11:20am
Fierce Pharma
Pfizer's chief strategist Andrew Baum to step down: reports
Apr 21, 2026 11:24am
